Richard Allan

1.0k total citations
39 papers, 661 citations indexed

About

Richard Allan is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Richard Allan has authored 39 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Physiology and 5 papers in Immunology and Allergy. Recurrent topics in Richard Allan's work include Inhalation and Respiratory Drug Delivery (11 papers), Asthma and respiratory diseases (11 papers) and Allergic Rhinitis and Sensitization (5 papers). Richard Allan is often cited by papers focused on Inhalation and Respiratory Drug Delivery (11 papers), Asthma and respiratory diseases (11 papers) and Allergic Rhinitis and Sensitization (5 papers). Richard Allan collaborates with scholars based in United Kingdom, United States and Australia. Richard Allan's co-authors include T. R. Watson, Dominic Kwiatkowski, Ieuan Jones, María Cristina De Salvo, William MacNee, Michael S. Roberts, Peter Braithwaite, J. Alexandra Rowe, John A. Williams and Nolan Wood and has published in prestigious journals such as Gastroenterology, Gut and Journal of Allergy and Clinical Immunology.

In The Last Decade

Richard Allan

37 papers receiving 625 citations

Peers

Countries citing papers authored by Richard Allan

Since Specialization

Citations

This map shows the geographic impact of Richard Allan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Allan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Allan more than expected).

Fields of papers citing papers by Richard Allan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Allan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Allan. The network helps show where Richard Allan may publish in the future.

Co-authorship network of co-authors of Richard Allan

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Allan. A scholar is included among the top collaborators of Richard Allan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Allan. Richard Allan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Wixela Inhub: Dosing Performance In Vitro and Inhaled Flow Rates in Healthy Subjects and Patients Compared with Advair Diskus 2020 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Andrew Cooper, James C. Parker, Mark Berry, (unknown), (unknown), Richard Allan	10
2	Wixela Inhub: A Generic Equivalent Treatment Option for Patients with Asthma or COPD 2020 ·Pulmonary Therapy ·James F. Donohue, (unknown), Jonathan K. Ward, Richard Allan, (unknown), Andrew Cooper	2
3	Usability and Robustness of the Wixela Inhub Dry Powder Inhaler 2020 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Richard Allan, (unknown), (unknown), Dave Singh, (unknown), Andrew Cooper, (unknown)	9
4	Clinical Bioequivalence of Wixela Inhub and Advair Diskus in Adults With Asthma 2019 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Dik Ng, Edward Kerwin, Martha V. White, S. David Miller, Scott Haughie, Jonathan K. Ward, Richard Allan	11
5	A Dose-Response Study Examining the Use of Methacholine Challenge to Demonstrate Local Therapeutic Equivalence of the Salmeterol Component of Generic Inhaled Fluticasone Propionate/Salmeterol Combination Products 2019 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Richard Allan, Scott Haughie, Richard C. Ahrens, Sachinkumar B. Singh, (unknown)	1
6	Equivalent Systemic Exposure to Fluticasone Propionate/Salmeterol Following Single Inhaled Doses from Advair Diskus and Wixela Inhub: Results of Three Pharmacokinetic Bioequivalence Studies 2019 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Scott Haughie, Richard Allan, Nolan Wood, (unknown)	10
7	Usability and Robustness of the Wixela® Inhub® Dry Powder Inhaler 2019 ·Richard Allan, (unknown), (unknown), (unknown), Jonathan K. Ward	0
8	Just in Case EoL Drugs in Patients' Homes - Prescribing and Outcomes in a Cancer Network 2014 ·Palliative Medicine ·(unknown), Russell E. Brown, Richard Allan	1
9	Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit 2014 ·Allergy Asthma and Clinical Immunology ·Michelle L. North, (unknown), Lisa M. Steacy, (unknown), Richard Allan, Frances Hackman, (unknown), Andrew G. Day, Anne K. Ellis	17
10	Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial 2013 ·Thorax ·William MacNee, Richard Allan, Ieuan Jones, María Cristina De Salvo, (unknown)	98
11	The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms 2011 ·Journal of Allergy and Clinical Immunology ·Jeffrey R. Stokes, F.A. Romero, Richard Allan, Peter Phillips, Frances Hackman, (unknown), Thomas B. Casale	41
12	Orale elementen in de Homerische grammatica: Intonatie-eenheid en enjambement 2009 ·VU Research Portal ·Richard Allan	3
13	Pharmacokinetics, Safety and Tolerance of Voriconazole in Renally??Impaired Subjects 2008 ·Clinical Drug Investigation ·Sylvie Abel, Richard Allan, Kuan Gandelman, Konrad E. Tomaszewski, David J. Webb, Nolan Wood	42
14	Effects of a 5‐HT₄ receptor agonist on oesophageal function and gastro‐oesophageal reflux: studies using combined impedance‐manometry and combined impedance‐pH 2006 ·Alimentary Pharmacology & Therapeutics ·Radu Țuțuian, Inder Mainie, Richard Allan, (unknown), Amit Agrawal, Janice Freeman, Jeremy D. Gale, D. O. Castell	29
15	Effect of voriconazole on the pharmacokinetics of omeprazole 2001 ·Nolan Wood, Keith Tan, Richard Allan, Anitra Fielding, D. J. Nichols	2
16	Structural analogues of ZAPA as GABAA agonists 1997 ·Neurochemistry International ·Richard Allan	8
17	Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease 1982 ·European Journal of Clinical Pharmacology ·Peter Braithwaite, Michael S. Roberts, Richard Allan, T. R. Watson	73
18	Crohn's disease involving the colon: an audit of clinical management. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Richard Allan, (unknown), John A. Williams, (unknown)	39
19	Changes in the bidirectional sodium flux across the intestinal mucosa in Crohn's disease. 1975 ·Gut ·Richard Allan, David M. Steinberg, K. E. Dixon, W. T. Cooke	32
20	An Incubation Flask to Study Metabolism of Foreign Compounds by Intestinal Microflora 1975 ·Xenobiotica ·Richard Allan, Andrea Tesoriero, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact